Evidence map›Paper›PMID 38195983›Full record

ArticleBone marrow transplantation2024

Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial.

Ruth M de Tute, Gordon Cook, David A Cairns, Julia M Brown, Jamie Cavenagh, A John Ashcroft, John A Snowden, Kwee Yong, Eleni Tholouli, Matthew Jenner and 5 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ruth M de TuteHaematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK. rdetute@nhs.net.
Gordon CookClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. g.cook@leeds.ac.uk.ORCID 0000-0003-1717-0412
David A CairnsClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.ORCID 0000-0002-2338-0179
Julia M BrownClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Jamie CavenaghDepartment of Haematology, Barts & The London NHS Trust, London, UK.
A John AshcroftMid-Yorks NHS Trust, Wakefield, UK.
John A SnowdenDepartment of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust & Department of Endocrinology & Metabolism, University of Sheffield, Sheffield, UK.ORCID 0000-0001-6819-3476
Kwee YongDepartment of Haematology, University College London, London, UK.
Eleni TholouliDepartment of Clinical Haematology, Manchester Royal Infirmary, Manchester Foundation Trust, Manchester, UK.
Matthew JennerUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Anna HockadayClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Mark T DraysonInstitute of Immunology and Immunotherapy University of Birmingham, Birmingham, UK.
Treen C M MorrisCollege of Myeloma, Belfast, UK.
Andy C RawstronHaematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK.
Roger G OwenHaematological Malignancy Diagnostic Service, Leeds Teaching Hospitals Trust, Leeds, UK.

Funding

Cancer Research UK 25447
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationMultiple MyelomaClinical Trials as TopicHumansNeoplasm Recurrence, LocalNeoplasm, ResidualStem Cell TransplantationTransplantation, Autologous

Identifiers

PMID38195983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.